Company / Depreciation & Amortization
BioRestorative Therapies, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$210.0K
FY2025
5-year range
$89.1K / $210.0K
FY2021-FY2025
Trend
+26.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $165,735 to $209,985 over the past 2 years.
Based on SEC 10-K filings.
$209,985 in FY2025 with a 5-year CAGR of -0.7%.
Increased from $165,735 to $209,985 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +20.3%
- 5-Year CAGR
- -0.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.7%, indicating a declining trend.
- In FY2025, depreciation & amortization increased 26.7% year-over-year.
- Peak depreciation & amortization was recorded in FY2018.
- Lowest depreciation & amortization in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $210.0K | +26.7% |
| FY2024 | $165.7K | +0.0% |
| FY2023 | $165.7K | +37.5% |
| FY2022 | $120.5K | +35.3% |
| FY2021 | $89.1K | -59.0% |
| FY2020 | $217.4K | -9.6% |
| FY2019 | $240.4K | -7.3% |
| FY2018 | $259.3K | +0.3% |
| FY2017 | $258.4K | +20.9% |
| FY2016 | $213.8K | +121.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026